XML 31 R16.htm IDEA: XBRL DOCUMENT
v3.25.3

Note 8 - Earnings per Share | 6 Months Ended
--- | ---
Sep. 30, 2025
Notes to Financial Statements |
Earnings Per Share [Text Block] | Note 8. Earnings Per Share The following table presents a reconciliation of the denominators used in the computation of basic and diluted earnings per share ("EPS"):
|  | Three Months Ended September 30, |  |  | Six Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Net income available for shareholders |  | $ | 2,476 |  |  | $ | 3,428 |  |  | $ | 7,218 |  |  | $ | 6,816 |
Weighted average outstanding shares of common stock |  |  | 5,512 |  |  |  | 5,413 |  |  |  | 5,488 |  |  |  | 5,405 |
Dilutive effect of RSUs |  |  | 23 |  |  |  | 58 |  |  |  | 55 |  |  |  | 43 |
Fully diluted shares |  |  | 5,535 |  |  |  | 5,471 |  |  |  | 5,543 |  |  |  | 5,448 |
Basic earnings per share |  | $ | 0.45 |  |  | $ | 0.63 |  |  | $ | 1.32 |  |  | $ | 1.26 |
Diluted earnings per share |  | $ | 0.45 |  |  | $ | 0.63 |  |  | $ | 1.30 |  |  | $ | 1.25 |
Potentially dilutive securities include stock options and unvested time and performance based RSUs (collectively "stock awards"). Stock awards are excluded from the calculation of diluted EPS if they are subject to performance or market conditions that have not yet been achieved as of our reporting date, or if their inclusion would be antidilutive. Shares underlying the Notes were also potentially dilutive until they matured on August 15, 2025; however, these shares have been excluded from the diluted EPS calculation for the amount of time they remained outstanding during three and six months ended September 30, 2025 and 2024 as assumed conversion under the if-converted method was antidilutive in each period. The following potentially dilutive securities were excluded from the calculation of diluted EPS:
|  | Three Months Ended September 30, |  |  | Six Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Assumed conversion of the Notes |  |  | 170 |  |  |  | 344 |  |  |  | 257 |  |  |  | 358 |
Stock awards that were anti-dilutive |  |  | 294 |  |  |  | 218 |  |  |  | 228 |  |  |  | 213 |
Total stock awards excluded from diluted EPS |  |  | 464 |  |  |  | 562 |  |  |  | 485 |  |  |  | 571 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration